2013 Press Releases
|11/12/13||GenVec Reports Third Quarter 2013 Financial Results|
|GAITHERSBURG, Md., Nov. 12, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced financial results for the third quarter and nine months ended September 30, 2013.
Third Quarter and Recent Corporate Highlights
Following an extensive review of the company's options and prospects, the board of directors withdrew the Plan of Complete Liquidation and Dissolution and approved a new operating strategy focused on maximizing the value of GenVec's technology and assets, including its ... |
|09/23/13||GenVec Announces Dismissal Of Class Action Lawsuit|
|GAITHERSBURG, Md., Sept. 23, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the previously disclosed putative class action lawsuit filed against the Company and certain of its current and former officers (the "Defendants") by the law firm of Brower Piven in the United States District Court for the District of Maryland has been dismissed with prejudice. No payment was made by any of the Defendants to the plaintiffs or their counsel in connection with the lawsuit. The Compan... |
|09/04/13||GenVec Board Restructures Operations and Withdraws Plan of Dissolution|
|CEO Cynthia Collins to leave Company effective immediately; and CFO Douglas Swirsky to assume role of CEO
GAITHERSBURG, Md., Sept. 4, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that its Board of Directors withdrew the Plan of Complete Liquidation and Dissolution for the Company previously adopted on May 24, 2013. The Company also announced that it will pursue a strategy focused on maximizing the value of its technology and assets, including its collaboration with Nova... |
|03/22/13||GenVec Reports Fourth Quarter And 2012 Year-End Financial Results|
GAITHERSBURG, Md., March 22, 2013 /PRNewswire/ -- Today GenVec, Inc. (NASDAQ: GNVC) announced financial results for the fourth quarter and year ended December 31, 2012. For the year ended December 31, 2012, the Company reported a net loss of $14.1 million, or $1.09 per share, compared with a net loss of $7.4 million, or $0.58 per share, for the year ended December 31, 2011. GenVec ended the year with $15.3 million in cash, cash equivalents, and short-term investments.
"In 2012 we conti... |
|03/15/13||GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013|
GAITHERSBURG, Md., March 15, 2013 /PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVC) will report financial results for the fourth quarter and year ended December 31, 2012 on Friday, March 22, 2013, before the U.S. financial markets open. The announcement will be followed by a webcast and conference call at 10:00 a.m. EDT to discuss the company's fourth quarter and 2012 financial results and 2013 business outlook.
To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) o... |
|03/12/13||GenVec to Present at 25th Annual ROTH Conference|
GAITHERSBURG, Md., March 12, 2013 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) announced today that Cindy Collins, GenVec's President and CEO, will present a Company overview highlighting recent developments starting at 4:00 p.m. PDT/7:00 p.m. EDT on Tuesday, March 19th at the upcoming 25th Annual ROTH OC Growth Stock Conference in Laguna Niguel, California.
A webcast of Ms. Collins' presentation will be available both live and on replay. The presentation will be available via webcast at ... |
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.